Get the Stockscreener App
46.30
4.32%
-2.09
After Hours:
46.33
0.03
+0.06%
Lazard Inc stock is traded at $46.30, with a volume of 1.22M.
It is down -4.32% in the last 24 hours and down -14.98% over the past month.
Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.
See More
Previous Close:
$48.39
Open:
$48.05
24h Volume:
1.22M
Relative Volume:
1.17
Market Cap:
$4.35B
Revenue:
$3.08B
Net Income/Loss:
$257.17M
P/E Ratio:
18.45
EPS:
2.51
Net Cash Flow:
$682.15M
1W Performance:
-12.49%
1M Performance:
-14.98%
6M Performance:
-17.94%
1Y Performance:
-4.32%
1-Day Range:
$45.80
$48.71
1-Week Range:
$45.80
$52.33
52-Week Range:
$31.97
$58.75
Lazard Inc Stock (LAZ) Company Profile
Name
Lazard Inc
Sector
Industry
Phone
(212) 632-6000
Address
30 ROCKEFELLER PLAZA, NEW YORK
Compare LAZ vs MS, GS, SCHW, HOOD, IBKR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LAZ
Lazard Inc
|
46.30 | 4.54B | 3.08B | 257.17M | 682.15M | 2.51 |
|
MS
Morgan Stanley
|
162.55 | 266.09B | 119.71B | 17.03B | 46.10B | 10.21 |
|
GS
Goldman Sachs Group Inc
|
835.46 | 260.11B | 126.15B | 17.18B | 23.15B | 51.30 |
|
SCHW
Charles Schwab Corp
|
95.41 | 170.66B | 27.68B | 8.85B | 13.27B | 4.6601 |
|
HOOD
Robinhood Markets Inc
|
80.56 | 74.01B | 4.51B | 1.88B | -3.42B | 2.059 |
|
IBKR
Interactive Brokers Group Inc
|
68.05 | 30.80B | 10.43B | 4.36B | 27.25B | 2.2111 |
Lazard Inc Stock (LAZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-26 | Initiated | BofA Securities | Buy |
| Dec-11-25 | Resumed | UBS | Neutral |
| Oct-03-25 | Initiated | BMO Capital Markets | Market Perform |
| Aug-25-25 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Apr-07-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-03-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Dec-20-24 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Dec-09-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-12-24 | Initiated | Wells Fargo | Equal Weight |
| Jan-29-24 | Resumed | Keefe Bruyette | Outperform |
| Jan-03-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-19-23 | Downgrade | Goldman | Neutral → Sell |
| Jul-13-23 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Jul-12-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-03-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Apr-12-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jul-18-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-13-22 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Apr-07-22 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Mar-08-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-04-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Oct-01-21 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Apr-07-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-14-21 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Dec-16-20 | Initiated | Seaport Global Securities | Buy |
| Dec-14-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Oct-02-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-23-20 | Initiated | Credit Suisse | Neutral |
| Apr-24-20 | Downgrade | CFRA | Hold → Sell |
| Mar-25-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-27-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-20-19 | Initiated | Morgan Stanley | Underweight |
| Jun-10-19 | Downgrade | UBS | Buy → Neutral |
| Apr-11-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-04-19 | Resumed | Keefe Bruyette | Mkt Perform |
| Nov-06-18 | Initiated | Goldman | Neutral |
| Apr-17-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-03-18 | Upgrade | Nomura | Neutral → Buy |
| Dec-21-17 | Downgrade | Buckingham Research | Buy → Neutral |
| Mar-23-17 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Feb-17-17 | Initiated | Keefe Bruyette | Outperform |
| Feb-03-17 | Reiterated | UBS | Buy |
| Jan-20-17 | Downgrade | Raymond James | Strong Buy → Outperform |
View All
Lazard Inc Stock (LAZ) Latest News
Lazard U.S. Convertibles Portfolio Q4 2025 Commentary - Seeking Alpha
Lazard, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
BEN's February AUM Rises on Positive Markets: Will the Upside Last? - TradingView
Victory Capital Management Inc. Decreases Holdings in Lazard, Inc. $LAZ - MarketBeat
Lazard, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
Lazard Adds Senior Healthcare Leaders As Shares Screen Undervalued - simplywall.st
Institution Moves: Can Lazard Inc sustain earnings growthWeekly Stock Recap & Weekly High Return Stock Opportunities - baoquankhu1.vn
Lazard Adds Allen And Co Veterans To Build Healthcare Deal Advisory - Yahoo Finance
Can Lazard Inc. reach all time highs this year2025 Price Targets & Community Consensus Trade Signals - mfd.ru
Lazard, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Market Metrics - Markets Mojo
Fisher Asset Management LLC Boosts Stock Holdings in Lazard, Inc. $LAZ - MarketBeat
BREAKINGVIEWS-Boutique bank deal champions long-term greed - Sahm
Royce & Associates LP Reduces Stock Position in Lazard, Inc. $LAZ - MarketBeat
Assessing Lazard (LAZ) Valuation After Profitability Squeeze And Insider Selling - Sahm
Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in January - Sahm
Tounjian Advisory Partners LLC Purchases New Holdings in Lazard, Inc. $LAZ - MarketBeat
Lazard (NYSE:LAZ) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Why Lazard (LAZ) Stock Is Down Today - Yahoo Finance
Lazard Global Total Return and Income Fund, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Lazard Veteran to Launch Hedge Fund for EM Bets at Bramshill - Bloomberg
Lazard, Inc. (NYSE:LAZ) Given Average Rating of "Hold" by Analysts - MarketBeat
New Healthcare Hires And Margin Pressure Might Change The Case For Investing In Lazard (LAZ) - simplywall.st
Vanguard Group Inc. Boosts Stake in Lazard, Inc. $LAZ - MarketBeat
Lazard, Inc. Common Stock (NY: LAZ - The Chronicle-Journal
Lazard International Equity Select Portfolio Q4 2025 Commentary - Seeking Alpha
Envestnet Asset Management Inc. Has $4.34 Million Stake in Lazard, Inc. $LAZ - MarketBeat
Decoding Lazard Inc (LAZ): A Strategic SWOT Insight - GuruFocus
Does Lazard (LAZ) Offer Value After Recent Share Price Softness? - Yahoo Finance
LAZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Lazard (LAZ) COO Alexandra Soto acquires 2,553 RSUs with staged vesting - Stock Titan
Lazard (LAZ) CAO Michael Gathy receives 92 new RSUs in grant - Stock Titan
Christopher Hogbin of Lazard (NYSE: LAZ) awarded 2,984 new RSUs - Stock Titan
Lazard (NYSE: LAZ) CFO adds 295 RSUs via dividend equivalent awards - Stock Titan
Lazard (LAZ) Releases Q4 2025 Earnings: Revenue Up but EPS Down - Quiver Quantitative
Lazard : Completes Sale of Edgewater Funds Interests - marketscreener.com
Lazard, Inc. SEC 10-K Report - TradingView
[10-K] Lazard, Inc. Files Annual Report | LAZ SEC FilingForm 10-K - Stock Titan
BREAKINGVIEWS-The Week in Breakingviews: When activists attack - Sahm
Alfa Gomma’s CEO, ICG Said to Partner on €1 Billion Buyout Plan - Bloomberg
Earnings Recap: Can Lazard Inc sustain earnings growthJuly 2025 Summary & Intraday High Probability Setup Alerts - baoquankhu1.vn
US Market Recap: Can Lazard Inc reach all time highs this year2025 Market Overview & Risk Controlled Swing Alerts - baoquankhu1.vn
Lazard Global Listed Infrastructure Portfolio Q4 2025 Commentary - Seeking Alpha
Assessing Lazard (LAZ) Valuation After Mixed Recent Share Price Performance - Sahm
LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOH - GuruFocus
Lazard Names John Koski and Rob Lowe as Healthcare Managing Directors - citybiz
Lazard, Inc. Announces Executive Appointments - marketscreener.com
LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE - Finviz
Lazard holds 8.7M Dentsply Sirona (XRAY) shares, 4.4% stake - Stock Titan
Why Lazard Inc. stock appeals to dividend seekers2025 Top Gainers & Stock Portfolio Risk Control - mfd.ru
Here's how Lazard's advisory push positions it for 2030 growth - MSN
Lazard Steps Into $450 Billion EM ETF Arena in Stock-Picking Bet - MSN
Lazard Inc Stock (LAZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.22%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):